 dose-searching phase ILE/II trials fractionation radiation therapy cancer article new design phase ILE/II dose searching prospective clinical trials total doses hyperfractionated radiation design experimental protocol statistical application ranking selection theory purpose certain margin error dose rate clinical response set doses tolerable terms acute days late days toxic effects LE number patients test toxicity various assumptions maximum total dose hyperfractionated radiation patients tumors therapy dose-dependent manner body sites lung upper respiratory digestive tract bladder brain regimens total doses differing increments Gy patients fractions Gy hours days week total dose level tolerable standard once-a-day radiation therapy tumor responses late toxic effects doses patients regimens acute effects early estimates late effects acceptable dose regimen additional patients total dose increment Gy assignment patients weighted manner numbers dose regimen rapid evaluation feasibility dose